recombinant human thrombopoietin

DRUG11 trials

Conditions

Aplastic Anemia (AA)Breast CancerCTIT-Chemotherapy Induced ThrombocytopeniaCancerCarcinoma, Non-Small-Cell LungGerm Cell TumorsHematopoietic Stem Cell MobilizationHematopoietic Stem Cell Transplantation

Early Phase 1

The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function Impairment

NCT03673215

Shenyang Sunshine Pharmaceutical Co., LTD.Liver Cirrhosis

Start: 2018-06-28End: 2020-12-31Target: 58Updated: 2020-03-23

The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function Impairment

NCT03673215

Shenyang Sunshine Pharmaceutical Co., LTD.Liver Cirrhosis

Start: 2018-06-28End: 2020-12-31Target: 58Updated: 2020-03-23

Phase 1

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

CompletedNCT00003597

Children's Oncology GroupCancer

Start: 1998-11-30End: 2005-09-30Updated: 2014-07-24

Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer

CompletedNCT00006225

Northwestern UniversityBreast Cancer, Leukemia, Lymphoma +2

Start: 1999-11-30End: 2004-01-31Updated: 2012-06-06

Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy

CompletedNCT00187109

St. Jude Children's Research HospitalGerm Cell Tumors, Hepatic Cancer, Neuroblastoma +2

Start: 2000-06-30End: 2007-02-28Target: 40Updated: 2008-04-10

Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation

NCT03014102

Hongnan MoHematopoietic Stem Cell Mobilization, Hematopoietic Stem Cell Transplantation, Thrombocytopoietin

Start: 2016-06-30End: 2020-09-30Target: 50Updated: 2019-12-06

Phase 2

Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy

TerminatedNCT01319669

Chinese Society of Lung CancerCarcinoma, Non-Small-Cell Lung

Start: 2011-02-28End: 2016-08-31Updated: 2017-03-03

Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA

Not yet recruitingNCT07400341

The First Affiliated Hospital of Soochow UniversityAplastic Anemia (AA), MDS (Myelodysplastic Syndrome)

Start: 2026-01-31End: 2028-12-31Target: 66Updated: 2026-02-10

Phase 3

Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune Thrombocytopenia

NCT03492515

Shandong UniversityImmune Thrombocytopenia

Start: 2018-05-01End: 2022-05-01Target: 90Updated: 2018-04-10

A Multicenter Randomized Controlled Study on the Treatment of Refractory CTIT With Romiplostim N01 Compared to Recombinant Human Thrombopoietin

Not yet recruitingNCT06440824

Shandong UniversityCTIT-Chemotherapy Induced Thrombocytopenia

Start: 2024-06-01End: 2025-11-30Target: 60Updated: 2024-06-04

Phase 4

Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients

CompletedNCT02267993

Institute of Hematology & Blood Diseases Hospital, ChinaThrombocytopenia

Start: 2014-10-31End: 2018-08-31Updated: 2025-05-30

Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU Patients

NCT05217719

Nanfang Hospital, Southern Medical UniversityPneumonia, Thrombocytopenia

Start: 2022-02-28End: 2023-10-31Target: 178Updated: 2022-02-01

Related Papers

Recombinant human thrombopoietin prior to mobilization chemotherapy facilitates platelet recovery in autologous transplantation in patients with lymphoma: Results of a prospective randomized study

Chronic Diseases and Translational Medicine2021-06-24